Hosein Golkashani is a Venture Scientist, with responsibility for due diligence of investment opportunities in the Synapto Ventures portfolio, as well as providing strategic and financial recommendations for fundraising.
Hosein is a clinician-scientist and entrepreneur with over 10 years of experience in clinical research, regulatory affairs, and innovation in the life sciences industry. Hosein has collaborated extensively with global healthcare leaders, startups, and industry pioneers to advance medical technologies and improve patient outcomes. His unique blend of scientific expertise, entrepreneurial experience, and regulatory acumen helps bridge innovation with commercial success in the life sciences sector.
Hosein has conducted multiple due diligence projects on healthcare companies, assessing their technical, regulatory, and market readiness for life sciences VC firms, including VentureBlick. Additionally, as a co-founder of a deep-tech medical startup, he has secured funding, and led regulatory approval processes, preclinical feasibility studies, and multi-site clinical trials for novel healthcare solutions. He has worked closely with key opinion leaders, investors, and cross-functional teams to align medical innovations with strategic goals, focusing on scalability, commercialization, and patient-centric design.
Throughout his academic career, Hosein has collaborated on projects integrating wearable technologies, and digital health data to enhance care efficiency and safety in both clinical and home settings. These initiatives included working with renowned companies like Fitbit, Garmin, and Oura Ring to validate and deploy innovative health monitoring tools. He has also advised startups on strategy and operations, leveraging his insights in evaluating medical technologies, regulatory frameworks, and investment potential to support fundraising campaigns, investor relations, and the successful launch of novel health solutions. His experience navigating regulatory landscapes, including compliance with ISO standards, 510(k) submissions, and post-market surveillance, also position him as a trusted venture scientist for life sciences VCs.
Hosein holds an MD-MPH from a top medical school, and PhD from the National University of Singapore with a focus on novel medical technologies and digital health solutions.
